Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval : vimarsana.com

HANGZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today that, VenusP-Valve, the company's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, cleared approval from Health Canada. As the first self-expanding TPVR product approved in China and Europe, VenusP-Valve carries remarkable...

Related Keywords

Canada , Spain , France , United Kingdom , Germany , Zhongshan , Anhui , China , Toronto , Ontario , Hangzhou , Zhejiang , Italy , Prnewswire Venus , Lee Benson , Venus Medtech , Jill Liu , Ophelia Chen , Venus Medtech Hangzhou Inc , Us Centers For Medicare Medicaid Services , Fudan University , Health Canada , Drug Administration , Cardiac Diagnostic , Interventional Unit , Sick Children , Medical Devices Regulation , Investigational Device Exemption , Medicaid Services , Lim Hou Sen , Chief Executive Officer , Academician Ge Junbo , Zhongshan Hospital ,